News
Reducing glucocorticoid use in the treatment of giant cell arteritis and polymyalgia ... Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and ...
Giant cell arteritis is a systemic vasculitis and careful attention should be given to the examination of the cardiovascular system including performing blood pressure measurements in both arms.
The following is a summary of “Biomarkers of ocular manifestation in newly diagnosed giant cell arteritis,” published in the April 2025 issue of BMC Ophthalmology by Terheyden et al. Giant cell ...
A total of 209 patients received upadacitinib at a dose of 15 mg, 107 received upadacitinib at a dose of 7.5 mg, and 112 received placebo; 70% of the patients had new-onset giant-cell arteritis ...
Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.
Alaska Native and American Indian adults have a high prevalence of AAV, with distinct clinical characteristics and treatment patterns observed.
A person may also experience: In the next phase, the person typically has eosinophilia, a condition when there are too many eosinophils, a type of white blood cell. The third phase is vasculitis ...
Duplex ultrasonography can also be used to assess vasculitis of subclavian and carotid ... as large-vessel giant cell arteritis is more common than previously thought The importance of ...
Studies of patients with PMR and giant-cell arteritis indicate that PMR could be a vasculitis limited to the subclavian or axillary arteries, or a synovitis or perisynovitis of the shoulders and hips.
RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval is supported by data from ...
Giant cell arteritis (GCA) is the most common form of vasculitis in the older adult population. There are variable clinical presentations of this entity and no perfect diagnostic test, often ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results